World Health Organization site
Skip Navigation Links

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Last refreshed on: 12 December 2020
Main ID:  NCT03440892
Date of registration: 14/02/2018
Prospective Registration: No
Primary sponsor: Vastra Gotaland Region
Public title: Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients SurviTreat
Scientific title: Longitudinal Observational Study on Rheumatoid Arthritis Patients: Effects of Antirheumatic Treatment on Serum Levels of Survivin
Date of first enrolment: November 1, 2017
Target sample size: 2500
Recruitment status: Recruiting
Study type:  Observational
Study design:   
Countries of recruitment
Name:     Sofia T Silfversw√§rd
Name:     Maria Bokarewa, MD
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients fulfilling the RA classification criteria according to the ACR/EULAR

Exclusion Criteria:

- Patients at stable/unchanged anti-rheumatic treatment

- Other serious physical or mental illness

- Lack of knowledge in Swedish making answering the questionnaires impossible

Age minimum: 20 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Rheumatoid Arthritis
Drug: abatacept
Drug: methotrexate
Drug: sulfasalazine
Drug: tocilizumab
Drug: tofacitinib/baricitinib
Primary Outcome(s)
Survivin status [Time Frame: 6 months]
Secondary Outcome(s)
Disease activity (DAS28) [Time Frame: 6 months]
Response to treatment [Time Frame: 6 months]
Secondary ID(s)
Survivin in Treatment
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results available:
Date Posted:
Date Completed:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history